Caffeine and caffeine-containing pharmaceuticals as promising inhibitors for 3-chymotrypsin-like protease of SARS-CoV-2
Amin O. Elzupir
Abstract
and clinical trial validation.Communicated by Ramaswamy H. Sarma.
Topics & Concepts
CaffeineIn silicoPharmacologyMolecular mechanicsChemistryProteaseCoronavirusMolecular dynamicsCoronavirus disease 2019 (COVID-19)BiochemistryMedicineEnzymeComputational chemistryInfectious disease (medical specialty)DiseaseInternal medicineGeneComputational Drug Discovery MethodsSARS-CoV-2 and COVID-19 ResearchLipid Membrane Structure and Behavior